|
Place de cotation: TORONTO
(IFM)
BCE Emergis supplies eBusiness
solutions to the financial services and health industries in North America,
automating transactions between companies and allowing them to interact
and transact electronically. The Company also provides cost containment
services for medical claims, mainly through its preferred provider network.
Its leading technologies are centred on claims and loan-related document
processing, electronic bill presentment and payment solutions.
BCE Emergis est un chef
de file nord-américain en solutions d'affaires électroniques
offrant des processus de transactions spécialisées aux secteurs
de la santé et des services financiers. BCE Emergis fournit aux
entreprises des solutions qui automatisent les transactions interentreprises
et leur permettent d'interagir et de faire des transactions par voie électronique.
La Société fournit aussi des services de compression des
coûts des remboursements médicaux, principalement par le biais
de notre réseau de prestataires privilégiés. Ses principales
technologies sont axées sur le traitement des demandes d'indemnisation
et de remboursement ainsi que sur la présentation électronique
des factures et des solutions de paiement.
Emergis
reports third quarter 2005 financial results
Revenue
at $40.1 M EBITDA at $6.5 M (16% of revenue), up substantially from Q3
2004 Net income from continuing operations at $0.1 M ($0.00 per share)
Updated guidance for 2005 and positive financial direction for 2006
Montréal,
November 2, 2005 — Emergis Inc. (TSX: EME) today announced its unaudited
financial results for the three-month period ended September 30, 2005.
All amounts are expressed in Canadian dollars, unless otherwise indicated.
Revenue
for the quarter was $40.1 million compared to $42.5 million in the third
quarter of 2004 and $40.7 million in the second quarter of 2005.
EBITDA1
increased to $6.5 million compared to $2.7 million in the third quarter
last year and $6.5 million in the second quarter of 2005. Excluding one-time
items in the comparison periods, EBITDA was $3.4 million in the third quarter
of last year and $5.3 million in the second quarter of 2005.
Net
income from continuing operations was $0.1 million ($0.00 per share) compared
to $0.4 million ($0.00) in 2004 and to $2.2 million ($0.02) in the second
quarter of 2005. Excluding one-time items in the comparison periods, the
third quarter 2004 figure was $1.1 million ($0.01) and that for the second
quarter 2005 was $1.0 million ($0.01).
Reported
total net loss for the quarter was $(1.2) million ($(0.01)) compared to
$(1.5) million ($(0.01)) in 2004 and net income of $11.5 million ($0.11)
in the second quarter of 2005.
One-time
items included income from contract settlements of $1.2 million during
the second quarter of 2005 and a restructuring charge of $0.7 million in
the third quarter of 2004. There were no one-time items in the current
quarter.
“Emergis
has reported another solid quarter of results, with continued growth in
our Health operations and a substantial improvement in EBITDA before one-time
items. In Finance we are tracking to plan post rationalization,” said François
Côté, President and Chief Executive Officer of Emergis. “We
expect to either meet or exceed our previously announced financial targets
for the year and are targeting an improved financial profile for 2006.”
|
